Clinical Trials Logo
  1. Home
  2. Intracytoplasmic Sperm Injection
  3. NCT03033563
  4. Details
NCT03033563 Clinical Trial

ICSI Outcome of Ejaculated Versus Extracted Testicular Spermatozoa

Intracytoplasmic Sperm Injection Clinical Trial

Official title:
ICSI Outcome of Ejaculated Versus Extracted Testicular Spermatozoa in Cryptozoospermic or Severe Oligozoospermic Men

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03033563
Other study ID # 2017
Secondary ID
Status Completed
Phase N/A
First received January 21, 2017
Last updated January 24, 2017
Start date January 1, 2012
Est. completion date December 31, 2014

Study information
Verified date January 2017
Source Adam International Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study is retrospective to compare ICSI outcome of patients with cryptozoospermia or severe oligozoospermia after use of ejaculated versus extracted testicular sperms in different cycles for the same patient.

Description:

The study was carried out on couples who underwent ICSI in period 2012-2014 for male factor infertility.Patients with semen showing cryptozoospermia were candidates for inclusion in this study.

First cycle was done as ICSI with priority to ejaculated sperm; testicular sperm was used if no motile sperm was available. For failed cases a second cycle was repeated using either testicular sperm or ejaculated sperm.

Keywords:Cryptozoospermia, ejaculated spermatozoa, testicular spermatozoa, ICSI.

Recruitment information / eligibility
Status Completed
Enrollment 430
Est. completion date December 31, 2014
Est. primary completion date December 1, 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Couples seeking ICSI.

Exclusion Criteria:

- Couples not seeking ICSI.

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Intracytoplasmic sperm injection
Intracytoplasmic sperm injection

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Adam International Hospital

Outcome
Type Measure Description Time frame Safety issue
Primary Intracytoplasmic sperm injection outcome Pregnancy rate. three years
See also
  Status Clinical Trial Phase
Completed NCT05567731 - Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve N/A
Not yet recruiting NCT03680690 - Pregnancy Rate in Women With Normal Uterine Cavity and Those With Corrected Uterine Lesions in ICSI Cycles
Active, not recruiting NCT04751084 - Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment N/A
Completed NCT05724979 - Outcome of Using Sperm Bound to the Zona Pellucida of Immature Oocytes for Intracytoplasmic Sperm Injection (ICSI) N/A
Recruiting NCT06243926 - Sperm Selection by Rheotaxis and Thermotaxis in In-Situ Handmade Microfluidics of Fluidic Walls in the Same ICSI Plate
Terminated NCT00866034 - Cetrotide Treatment Optimization Phase 4
Completed NCT04727671 - Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients. Phase 4
Completed NCT04724343 - Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes. Phase 4
Completed NCT05578118 - Health of Children Born From ICSI With AOA (AOA-BABIES)
Completed NCT04724486 - Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI Phase 4
Completed NCT04727684 - Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI Phase 4